Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Sharp Rees-Stealy Medical Group leverages Allscripts EHR to achieve HIMSS Analytics O-EMRAM Stage 7

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  ALLSCRIPTS

Nuvectra® to Report Third Quarter 2018 Financial Results on October 29, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Nuvectra Corporation

Arbutus Names New Members to its Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Arbutus Biopharma Corporation

VistaGen Therapeutics to Present at Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  VistaGen Therapeutics, Inc.

Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Resverlogix Corp.

Hemispherx Outlines Ampligen Combination Therapy Clinical Study Strategy for the Treatment of Multiple Cancers in Letter to Stockholders

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Hemispherx BioPharma

Corvus Pharmaceuticals Announces New Data on Adenosine Gene Signature Biomarker Associated with Patient Response to CPI-444 at European Society for Medical Oncology (ESMO) 2018 Congress

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Corvus Pharmaceuticals, Inc.

Transactions under Novozymes’ stock buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Novozymes A/S

Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Cybrexa Therapeutics

Novo Nordisk A/S - Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Novo Nordisk A/S

Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Kura Oncology, Inc.

Clients save Millions in Drug Spend through the use of Innovative Pharmacy Analytics for Hospitals and Health Systems

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018

RedHill Biopharma Announces Additional Data from Positive Phase III Study of RHB-104 in Crohn’s Disease at United European Gastroenterology (UEG) Week 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  RedHill Biopharma Ltd.

New Imaging and Interventional Solutions Plus Expanded Support for Education on Display by Konica Minolta at AAPM&R 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018

R1 Expands Physician Practice Footprint with CarePoint Health and Holston Medical Group

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  RCM&D

Immunicum AB (publ) Announces Upcoming Investor Events in October and November

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Immunicum AB

Joint Commission International to hold conference in Dubai

Program educates on how to achieve up-to-date accreditation under current hospital standards

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018

Reistone Biopharma, a new Chinese biotech company ready to initiate its Ulcerative Colitis phase II clinical trial globally

SHANGHAI, Oct. 22, 2018 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company headquartered in Shanghai, today announced the US FDA approval of IND for phase II clinical trial to investigate the efficacy and safety of selective Janus Kinase... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018

PLENVU® (NER1006) the First 1 Litre Bowel Preparation to Show Superior High-quality Segmental Cleansing of the Colon Compared to Standard of Care[I]

AMSTERDAM, October 22, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018

New real-world evidence confirms utility of the Oncotype DX® test in clinical practice for patients with early-stage breast cancer

- Further demonstrates the test's ability to change clinical chemotherapy treatment decisions by more precisely identifying patients who will or will not benefit from chemotherapy hence targeting treatment more effectively

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑